Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Antivenom Market Growth in 2025?

Over the past few years, the antivenom market has experienced robust expansion. It is projected to rise from $1.92 billion in 2024 to $2.06 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. Growth in the past span can be linked to factors such as the high frequency of snakebites, the geographical spread of harmful snakes, inadequate availability of healthcare services, agricultural and rural pursuits, along with public health drives.

What Is the Forecast for the Antivenom Market Size Through 2029?

A substantial increase in the size of the antivenom market is projected over the upcoming years, expanding to “$2.74 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.4%. This expansion during the prediction period is largely credited to factors such as alterations in snake living conditions due to climate change, increased population in areas prone to snake influence, development in antivenom compositions, initiatives in global health security, and joint ventures for the advancement of antivenom. Key trends over the prediction period are expected to include the inclusion of data analytics, heightened emphasis on education and training, strategic partnerships for upscaling production, improvements in the regulatory frameworks, and research exploration of new therapeutic targets.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10798&type=smp

What are the Key Market Players in Antivenom Market and How They’re Evolving?

Major companies operating in the antivenom market include Pfizer Inc., Commonwealth Serum Laboratories, Merck KGaA, Incepta Pharmaceuticals Limited, Bharat Serums and Vaccines Limited, Rare Disease Therapeutics Inc., Vins Bioproducts Limited, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Haffkine Bio-Pharmaceutical Corporation Limited, MicroPharm Limited, Latoxan SAS, Serum Institute of India Pvt. Ltd., BSV Group, Shanghai Serum Biotech Co Ltd., British Technology Group International, South African Vaccine Producers, Bioclon Institute, Inosan Biopharma, Instituto Bioclon S.A. de C.V., F. Hoffmann-La Roche AG, Protherics Inc., Sanofi Pasteur SA, Venom Supplies Pty Ltd, Instituto Clodomiro Picado, Laboratorios Silanes S.A. de C.V., Instituto Biológico Argentino S.A., Instituto Vital Brazil, Instituto Butantan, Instituto Nacional de Producción de Biológicos, Instituto de Biotecnología de la UNAM

What Are the Primary Growth Drivers in the Antivenom Market?

The antivenom market is predicted to expand due to the increasing incidence of snake bites. These bites from venomous snakes can lead to a potentially lethal disease due to the snake’s toxins. Antivenom is a specific treatment that, if administered promptly and in sufficient therapeutic doses, has the potential to prevent or even reverse most symptoms of snakebite envenoming. For instance, the World Health Organization (WHO), a public health-focused United Nations organization based in Switzerland, stated in September 2023 that roughly 5.4 million people around the world suffer from snake bites each year, leading to between 1.8 to 2.7 million cases of envenoming. Consequently, about 81,410 to 137,880 people die from snake bites each year. The current approach is aiming for a 50% decline in mortality and disability resulting from snakebite envenoming by 2030. Hence, the rising incidence of snake bites fuels the growth of the antivenom market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10798&type=smp

What Are the Leading Segments in the Global Antivenom Industry?

The antivenom market covered in this report is segmented –

1) By Type: Monovalent, Polyvalent, Other Types

2) By Animal: Snakes, Scorpions, Spiders, Other Animals

3) By Mode of Action: Cytotoxic, Neurotoxic, Hemotoxic, Cardiotoxic, Myotoxic, Other Modes Of Action

4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Monovalent: Specific Antivenoms For Individual Snake Species, Specific Antivenoms For Individual Venom Types

2) By Polyvalent: Broad-Spectrum Antivenoms, Regional Polyvalent Antivenoms

3) By Other Types: Antivenoms For Other Venoms, Recombinant Antivenoms, Antivenom For Rare Venoms

What Are the Key Market Trends in the Antivenom Industry?

Leading businesses in the antivenom market are pioneering advanced technologies like public-benefit target products to boost the efficiency, safety, and availability of antivenoms. Their ultimate goal is to enhance patient results and lessen the global impact of snakebite poisoning. Public-benefit target products are healthcare innovations or medical goods generated primarily to meet unique public health needs, especially in neglected or vulnerable communities. For example, in June 2023, Bharat Serums and Vaccines Ltd., a US biopharmaceutical firm, partnered with the Indian Institute of Science, a public institution from India, to create region-specific antivenoms for snakebites in the country. This cooperation seeks to heighten the effectiveness of treatments and minimize the public health consequences of snakebites in the regions affected.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antivenom-global-market-report

What Is the Regional Outlook for the Antivenom Market?

North America was the largest region in the global antivenom market size in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antivenom market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10798

This Report Delivers Insight On:

1. How big is the antivenom market, and how is it changing globally?

2. Who are the major companies in the antivenom market, and how are they performing?

3. What are the key opportunities and risks in the antivenom market right now?

4. Which products or customer segments are growing the most in the antivenom market?

5. What factors are helping or slowing down the growth of the antivenom market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model